SplitMay 26, 2026, 08:32 AM
Silexion Announces 1-for-10 Reverse Share Split
AI Summary
Silexion Therapeutics Corp. announced a 1-for-10 reverse share split of its ordinary shares, effective after market close on May 28, 2026. Trading on a split-adjusted basis will commence on May 29, 2026, under the existing ticker symbol "SLXN." The par value will increase from $0.0135 to $0.135 per share, with no fractional shares issued. This strategic move is intended to maintain Nasdaq listing compliance, strengthen the capital structure, reduce volatility, and improve flexibility for future financings as the company approaches a Phase 2/3 trial for SIL204.
Key Highlights
- Silexion Therapeutics announced a 1-for-10 reverse share split.
- The split becomes effective after market close on May 28, 2026.
- Shares will trade on a split-adjusted basis starting May 29, 2026.
- Par value per share will increase from $0.0135 to $0.135.
- The split aims to maintain Nasdaq minimum bid price compliance.
- It is intended to reinforce capital structure and enable equity financings.
- No fractional shares will be issued; rounded up for DTC participants.
Price Impact
More from SLXN